|
December
2005 - Issue 8
Go to EuropaBio home page
Be representative at European level -
Become a member !
To learn more about becoming a member of
EuropaBio,
and the benefits, click
here
EuropaBio supported project gets EC funding for Young and
Innovative Biotech companies, Belgium adopts the YIC
Belgium
announced its intention to follow France and adopt the Young
Innovative Company (YIC) initative. Meanwhile, Biotech
associations from five European countries have joined an
initiative to promote the Young Innovative Company (YIC) status
in their countries The project is supported by EuropaBio, France
Biotech, the French biotech association, the European
Association for Bioindustries, and is funded by the European
Commission.
http://www.checkbiotech.org/root/index.cfm?fuseaction=newsletter&topic_id=3&subtopic_id=16&doc_id=11699
New innovation and Research Action Plan - 19 measures to boost
research
Following Commission proposal, European Union Research and
Industry Ministers have now backed the action plan
http://europa.eu.int/rapid/pressReleasesAction.do?reference=IP/05/1252&format=HTML&aged=0&language=EN&guiLanguage=en
EuropaBio lobbies FP7 actors
The EU's Seventh Framework Programme for Research and
Development was debated by EU Industry and Research Ministers at
the Competitiveness Council in Brussels on November 28-29 where
The Council approved, by a large majority, the non budgetary
elements of the 7th Framework Programmes (FP7) for research and
technological development and focussed on giving “the adequate
support for small and medium-sized enterprises participation in
research projects”. This paves the way for future discussions
on budget and how the money should be spent. Still a long way
to go…12th of October the EU Commission announced a
major cut down on red tape for EU contracts and grants and
promised to simplify significantly the administrative burden for
companies, SMEs and beneficiaries of EU grants.
http://www.europa.eu.int/rapid/pressReleasesAction.do?reference=IP/05/1257&format=HTML&aged=0&language=EN&guiLanguage=en
EuropaBio invited to be a member of the Board of EPPOSI
EPPOSI is the European Platform for Patients' Organisations,
Science and Industry (EPPOSI) - a EU patient-led partnership
between patients, industry and academic science, founded in 1994
for the exchange of information and discussion of policies in EU
human healthcare.
http://www.epposi.org/
Concerns raised over impact of clinical trials directive
Concerns have been expressed at the 13th European Cancer
Conference in Paris that the recently introduced EU clinical
trials Directive is having a restrictive effect on the number of
new cancer trials being carried out in Europe. The aims of the
Directive - to harmonise legal provisions for the establishment,
conduct and reporting of clinical trials, implement good
clinical practice and ensure patient safety - are noble,
according to a statement by the Federation of European Cancer
Societies (FECS).
http://icadc.cordis.lu/fep-cgi/srchidadb?CALLER=EN_NEWS&ACTION=D&RCN=24704&DOC=10&CAT=NEWS&QUERY=1
For more information on the European Cancer Conference,
please visit:
http://www.fecs.be/emc.asp?pageId=10&Type=P
EuropaBio ready to be the voice of the biotech industry as member of the
new pharmaceutical forum, post G-10
EuropaBio has been officially invited by Günter Verheugen and
Markos Kyprianou (EC) to be a full partner in the pharmaceutical
forum, the pharmaceutical forum steering committee and the
working groups,also known as G10 medicines.
This invitation confirms that EuropaBio is recognised as an
important representative of the European-based pharmaceutical
industry. The 1st meeting of the Steering Committee
is planned for 6/12/2005.
EuropaBio
campaigning on advanced therapies bears fruit as Commission
unveils new rules
The Commission published new EU wide rules to facilitate gene,
cell and tissue-based therapies. The Proposal is to have a
centralised marketing authorization procedure, a new expert
Committee, strengthened requirements for risk management and
traceability and top-quality scientific advice. Ethical
decisions about the use or non-use of germ cells or embryonic
stem cells remain under the full responsibility of individual
Member States.
EuropaBio Industry Hearing on Advanced Therapies
Over one hundred stakeholders attended the EuropaBio Industry
Hearing in Brussels. All presentations now available from the
web site
http://www.europabio.org/events/IndustryHearing/index.htm
EuropaBio
lobby efforts pay off for Healthcare Biotech SMEs - new SME
services and major fee reductions announced at EMEA
New
rules at the EMEA to facilitate SMEs access are almost complete.
EuropaBio has been working for a long time on this and it is
exciting that the new incentives are becoming a reality. EMEA
stakeholder meeting was held on 17 November. The Fees Regulation
was adopted mid November and the SME Regulation is due to be
adopted end of year. Meanwhile EuropaBio has created a new
Mirror Group EMEA-SMEs to accompany the implementation phase.
Commission press release http://europa.eu.int/rapid/pressReleasesAction.do?reference=IP/05/1439&format=HTML&aged=0&language=EN&guiLanguage=en
EuropaBio publishes a research agenda for white biotech
The final leg of the Research Agenda as contribution from
stakeholders to the SusChem Technology Platform is at an end.
The full research programme for white biotech can be downloaded
from the EuropaBio web site and as well as the new BioEconomy.
Web portal.
www.bio-economy.net and
www.europabio.org
Survey on Stakeholders' Perception of White Biotechnology
The survey was carried out within the EU funded project "Medium
and long-term opportunities and risks of the biotechnological
production of bulk chemicals from renewable resources (BREW)".
It depicts the range of prevailing views and attitudes that
leading stakeholders in Europe express about the emerging field
of White Biotechnology.
The survey results are now available at
http://www.chem.uu.nl/brew/BREWsymposiumWiesbaden11mei2005/WEBSITEWiesbaden.pdf
Other findings from the project are also accessible via
http://www.chem.uu.nl/brew/BREWsymposiumWiesbaden11mei2005/overviewpresentations.htm
Biorefineries
Call for proposals (currently opened) which includes an IP topic
on biorefineries (pag.32 of the workprogramme).
The call closes on January 10th.
http://fp6.cordis.lu/index.cfm?fuseaction=UserSite.FP6DetailsCallPage&call_id=236
EuropaBio feedback from Environment Council public debate on
GMOs
EuropaBio prepared briefing paper on benefits of biotech crop
production for National Associations and member companies.
The
debate was
rather negative and was centered
around the need in their view to to
review the decision-making procedure for approving GMOs, particularly
comitology rules, as well as the need to conduct more research
and provide the public with more information on
genetically-modified organisms, There are several reports due
and that these were needed to feed into more serious policy
discussions which would have to wait until Spring, under the
Austrian Presidency.
Events coming up:
- Coexistence Conference in Vienna, April 4th, 2006
- Commission to publish report on coexistence - February 2006
- Report on Review of 2001/18 due end 2006
- Report on Traceability and labelling to be released beginning
2006
- WTO verdict expected January 2006
EuropaBio Job PLAZA – Post your vacancies Free-of-Charge
The
EuropaBio Life Science Jobs in Europe database offers the possibility of
posting job vacancies in the European biotech industry. The database is
open to all European biotech companies; there is no registration or
login required.
Surf to and post at:
http://www.europabio.org/jobs.htm
|
